CHAPTER 1 INTRODUCTION

1.1 Key Benefits
1.2 Key Market Segments
1.3 Key Audiences
1.4 Research methodology

1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1 Market beyond what to expect by 2025 ($Million)

2.1.1 Moderate growth scenario
2.1.2 Rapid growth scenario
2.1.3 Diminishing growth scenario

CHAPTER 3 MARKET OVERVIEW

3.1 Market Definition and Scope
3.2 Technological Advancements: Multimodality In Vivo Imaging

3.2.1 Multimodality Imaging
3.2.2 Cloud Computing and Real Time Data Storage

3.3 Emerging Economies as a beneficial criterion for investors
3.4 Key Findings

3.4.1 Top factors impacting for small animal imaging (In Vivo) market
3.4.2 Top investment pockets for small animal imaging (In Vivo) market
3.4.3 Top winning strategies for small animal imaging (In Vivo) market

3.5 Government Regulations and reimbursement

3.5.1 Regulations in United States
3.5.2 Regulations in Europe
3.5.3 Regulations in Asia Pacific
3.5.4 Reimbursement Scenario

3.6 Porter's Five Force Analysis

3.6.1 Bargaining power of Suppliers (Lower)
3.6.2 Bargaining power of buyers (High)
3.6.3 Threats from substitute products (High)
3.6.4 Threat from new entrants (Low)
3.6.5 Moderate Industry rivalry

3.7 Value chain analysis
3.8 Patent Analysis

3.8.1 Patent Analysis by type of patents
3.8.2 Patent Analysis by Geography

3.9 Key market player positioning (2013)
3.10 Market dynamics

3.10.1 Growth Drivers

3.10.1.1 Increasing use of Multi functional pre clinical imaging
3.10.1.2 rising investments from clinical research organizations for pre clinical studies
3.10.1.3 rising number of pharmaceutical organizations and research institutions
3.10.1.4 Technological innovations such as combination of high resolution mri with other imaging modalities future growth driver

3.10.2 Restraints

3.10.2.1 Stringent regulatory requirements
3.10.2.2 Inadequate reimbursements a barrier in In vivo imaging devices adoption
3.10.2.3 Accuracy and cost a hindrance in worldwide adpotion of small animal imaging techniques

3.10.3 Opportunities

3.10.3.1 Development of new high resolution in vivo imaging techniques
3.10.3.2 Ultrasound contrast imaging techniques An Opportunity to improve efficiency in the pre clinical drug discovery and development process

CHAPTER 4 GLOBAL SMALL ANIMAL IMAGING (IN VIVO) MARKET BY TECHNOLOGY

4.1 Micro Magnetic Resonance Imaging

4.1.1 Key market trends
4.1.2 Key growth factors and opportunities
4.1.3 Market size and forecast

4.2 Optical Imaging

4.2.1 Key market trends
4.2.2 Key growth factors and opportunities
4.2.3 Market size and forecast
4.2.4 Bioluminescence Imaging
4.2.5 Cerenkov Luminescence Imaging
4.2.6 Fluorescence Imaging

4.3 Nuclear Imaging

4.3.1 Key market trends
4.3.2 Key growth factors and opportunities
4.3.3 Market size and forecast
4.3.4 Micro Positron Emission Tomography (Micro PET)
4.3.5 Micro Single Photon Emission Computerized Tomography (Micro SPECT)

4.4 Other Imaging Modalities

4.4.1 Micro Computerized Tomography Imaging

4.4.1.1 Key market trends
4.4.1.2 Key growth factors and opportunities

4.4.2 Micro Ultrasound Imaging

4.4.2.1 Key Market Trends
4.4.2.2 Key Growth Factors and Opportunities
4.4.2.3 Market size and forecast

CHAPTER 5 GLOBAL SMALL ANIMAL IMAGING (IN VIVO) MARKET BY APPLICATION

5.1 Monitoring Treatment Response

5.1.1 Market Size and forecast

5.2 Biodistribution, Determining Drug/Target Engagement

5.2.1 Market Size and forecast

5.3 Cancer cell detection

5.3.1 Market Size and forecast

5.4 Biomarkers

5.4.1 Market Size and forecast

5.5 Longitudinal studies

5.5.1 Market Size and forecast

5.6 Epigenetics

5.6.1 Market Size and forecast

CHAPTER 6 GLOBAL SMALL ANIMAL IMAGING (IN VIVO) MARKET BY GEOGRAPHY, 2013 2020, $MILLION

6.1 North America

6.1.1 Key Market Trends
6.1.2 Key growth factors and opportunities
6.1.3 Market size and forecast

6.2 Europe

6.2.1 Key market trends
6.2.2 Future growth factors and opportunities
6.2.3 Market size and forecast

6.3 Asia Pacific

6.3.1 Key market trends
6.3.2 Key growth factors and opportunities
6.3.3 Market size and forecast

6.4 LAMEA

6.4.1 Key market trends
6.4.2 Future growth factors and opportunities
6.4.3 Market size and forecast

CHAPTER 7 COMPANY PROFILES

7.1 Thermo Fisher Scientific

7.1.1 Company overview
7.1.2 Company snapshot
7.1.3 Operating business segment overview
7.1.4 Business performance
7.1.5 Strategic moves and developments
7.1.6 SWOT analysis

7.2 Siemens AG

7.2.1 Company overview
7.2.2 Company snapshot
7.2.3 Operating business segment overview
7.2.4 Siemens AG Business Performance
7.2.5 Strategic Moves And Developments
7.2.6 SWOT analysis of Siemens AG

7.3 Mediso Medical Imaging Systems

7.3.1 Company profile
7.3.2 Company snapshot
7.3.3 Operating business segment overview
7.3.4 Strategic moves and developments
7.3.5 SWOT analysis

7.4 Life Technologies Corporation

7.4.1 Company profile
7.4.2 Company snapshot
7.4.3 Operating business segment overview
7.4.4 Business performance
7.4.5 Strategic moves and developments
7.4.6 SWOT analysis of Life Technologies Corporation

7.5 Promega Corporation

7.5.1 Company profile
7.5.2 Company snapshot
7.5.3 Operating business segment overview
7.5.4 Business performance
7.5.5 Strategic Moves And Developments
7.5.6 SWOT analysis of Promega Corporation

7.6 Miltenyi Biotech GmbH

7.6.1 Company profile
7.6.2 Company snapshot
7.6.3 Operating business segment overview
7.6.4 Business Performance
7.6.5 Strategic moves and developments
7.6.6 SWOT analysis

7.7 Bruker Corporation

7.7.1 Company profile
7.7.2 Company snapshot
7.7.3 Operating business segment overview
7.7.4 Business Performance of Bruker Corporation
7.7.5 Strategic moves and developments
7.7.6 SWOT analysis of Bruker Corporation

7.8 FUJIFILM Holdings Corporation

7.8.1 Company Profile
7.8.2 Company snapshot
7.8.3 Business Performance of FujiFilm Holding Corporation
7.8.4 Business Performance of FujiFilm Holding Corporation:
7.8.5 Strategic moves and developments
7.8.6 SWOT Analysis of FujiFilm Holding Corporation

7.9 PerkinElmer, Inc.

7.9.1 Company Overview
7.9.2 Business Performance of PerkinElmer Inc.
7.9.3 Business Performance of PerkinEmer Inc.:
7.9.4 Strategic Moves and Development
7.9.5 SWOT analysis of PerkinElmer Inc.

7.10 Aspect Imaging Ltd.

7.10.1 Company Overview
7.10.2 Company snapshot
7.10.3 Business Performance of Aspect Imaging Ltd.
7.10.4 Strategic moves and developments
7.10.5 SWOT analysis